Clinics (Sao Paulo, Brazil) · 2026
Genetic predisposition to smoking and the risk of Carpal Tunnel Syndrome: a mendelian randomization study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zeng Qi, Rao Xuepeng, Hu Weiwen, Chao Haichao, Cheng Yu, Zheng Guanghao
Аннотация
BACKGROUND: Carpal Tunnel Syndrome (CTS) is a common entrapment neuropathy leading to pain and functional impairment. While smoking has been proposed as a modifiable risk factor, evidence from observational studies remains inconsistent due to potential confounding and reverse causality.
METHOD: The authors performed a two-sample Mendelian Randomization (MR) analysis to assess the causal relationship. Genetic instruments for five smoking phenotypes were derived from large-scale Genome-Wide Association Studies (GWAS). Summary-level data for CTS were obtained from the FinnGen Consortium (n = 480,201). The Inverse Variance Weighted (IVW) method was the primary analysis, supplemented by four other MR methods and a suite of sensitivity analyses to assess robustness and pleiotropy.
RESULTS: Genetically predicted smoking propensity was associated with a higher risk of CTS. Specifically, genetic predisposition to smoking initiation (ORMR-IVW = 1.53; 95% CI 1.33-1.76; p < 0.001) and heavier cigarette consumption (ORMR-IVW = 1.52; 95% CI: 1.31-1.77; p < 0.001) significantly increased CTS risk. The estimate for current smoking was particularly strong (ORMR-IVW=3.96; 95% CI 2.20-7.12; p < 0.001). Sensitivity analyses were largely consistent, though some heterogeneity and potential pleiotropy were detected for specific phenotypes.
CONCLUSIONS: This MR study supports a causal role of smoking in the development of CTS. These findings underscore the importance of smoking cessation as a potential preventive measure against CTS and should be integrated into patient counseling and public health strategies.
METHOD: The authors performed a two-sample Mendelian Randomization (MR) analysis to assess the causal relationship. Genetic instruments for five smoking phenotypes were derived from large-scale Genome-Wide Association Studies (GWAS). Summary-level data for CTS were obtained from the FinnGen Consortium (n = 480,201). The Inverse Variance Weighted (IVW) method was the primary analysis, supplemented by four other MR methods and a suite of sensitivity analyses to assess robustness and pleiotropy.
RESULTS: Genetically predicted smoking propensity was associated with a higher risk of CTS. Specifically, genetic predisposition to smoking initiation (ORMR-IVW = 1.53; 95% CI 1.33-1.76; p < 0.001) and heavier cigarette consumption (ORMR-IVW = 1.52; 95% CI: 1.31-1.77; p < 0.001) significantly increased CTS risk. The estimate for current smoking was particularly strong (ORMR-IVW=3.96; 95% CI 2.20-7.12; p < 0.001). Sensitivity analyses were largely consistent, though some heterogeneity and potential pleiotropy were detected for specific phenotypes.
CONCLUSIONS: This MR study supports a causal role of smoking in the development of CTS. These findings underscore the importance of smoking cessation as a potential preventive measure against CTS and should be integrated into patient counseling and public health strategies.